Ognjen Ležakov
Biographic Data
| ID | 8264281 |
|---|---|
| NAME | Ognjen Ležakov |
| GIVEN NAMES | Ognjen |
| FAMILY NAME | Ležakov |
| SIGNATURE | LEŽAKOV O |
| AFFILIATIONS | University of Novi Sad |
| ORCID | 0009-0007-0354-0458 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Sarcoidosis-like Skin Lesions as the First Manifestation of Ataxia-Telangiectasia
Ataxia-telangiectasia is a rare autosomal recessive disorder that is difficult to diagnose due to its unpredictable presentation. It is characterized by cerebellar degeneration, telangiectasias, immunodeficiency, frequent pulmonary infections, and tumors. Immune system abnormalities manifest as disruptions in both cellular and humoral immunity. The most common findings include decreased levels of immunoglobulin classes (IgA, IgM, IgG, and IgG sub…
TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease
Prior to the initiation of azathioprine therapy, TPMT genotyping should be performed to prevent adverse effects and ensure optimal drug dosing. Identification of the HLA-DQA105 and HLA-DQA101 alleles plays an important role in the planning of biological therapy regimens, including decisions on dose escalation or interval shortening
No prominent works on this page.
Sarcoidosis-like Skin Lesions as the First Manifestation of Ataxia-Telangiectasia
Ataxia-telangiectasia is a rare autosomal recessive disorder that is difficult to diagnose due to its unpredictable presentation. It is characterized by cerebellar degeneration, telangiectasias, immunodeficiency, frequent pulmonary infections, and tumors. Immune system abnormalities manifest as disruptions in both cellular and humoral immunity. The most common findings include decreased levels of immunoglobulin classes (IgA, IgM, IgG, and IgG sub…
TPMT and HLA-DQ Allelic Variants in Relation to Drug Response, Safety and Need for Therapy Optimization in Pediatric Inflammatory Bowel Disease
Prior to the initiation of azathioprine therapy, TPMT genotyping should be performed to prevent adverse effects and ensure optimal drug dosing. Identification of the HLA-DQA105 and HLA-DQA101 alleles plays an important role in the planning of biological therapy regimens, including decisions on dose escalation or interval shortening
Adverse effect (1 work) · Allele (1 work) · Ataxia (1 work) · Ataxia-telangiectasia (1 work) · Autoimmune Neurological Disorders and Treatments (1 work) · Azathioprine (1 work) · Biology (1 work) · Dermatology (1 work) · Disease (1 work) · DNA Repair Mechanisms (1 work)